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Abstract 
Objective   The pathways from internalizing psychopathology to substance misuse remain 
largely unclear. We estimated associations between childhood internalizing problems and 
subsequent substance misuse in two family-based samples. We also investigated sex 
differences and the role of externalizing comorbidity. 
Method   We studied associations of childhood internalizing psychopathology with register-
based substance misuse after age 13. Sample 1 included all individuals born in Sweden 1984–
2000 (N=1,768,516). Depressive and anxiety disorders were included as register-based ICD-
9/10 diagnoses before age 13. Sample 2 was a sub-sample within the population sample, the 
Swedish CATSS twin cohort (n=12,408; born 1992–1998), with mood and anxiety problems 
assessed at age 9/12 by parents. In both samples, substance misuse was defined as an ICD-
9/10 alcohol/drug use disorder or an alcohol/drug-related criminal conviction until December 
2013. To account for familial effects, stratified analyses were conducted within siblings and 
twin pairs. 
Results   In the population sample, both depressive (HR=2.75 [95% CI: 2.36–3.20]) and 
anxiety disorders (HR=1.52 [1.35–1.73]) were associated with substance misuse. Childhood 
mood problems (HR=2.28 [1.69–3.08]) were associated with substance misuse in the CATSS 
sample. The associations were partially explained by familial factors, and comorbid 
externalizing disorders explained the associations in men but not in women. 
Conclusion   Childhood mood problems were associated with substance misuse but familial 
factors shared by siblings partially explained the associations. The relationship of anxiety 
with substance misuse was complex and depended on measurement and the type of anxiety 





In a study of two large community-based samples from Sweden, childhood depression and 
anxiety were associated an increased risk of subsequent alcohol or drug use problems. 
Depression was consistently associated with substance misuse whereas the relationship of 
anxiety with substance misuse was complex and depended on the measurement and the type 
of anxiety disorder. Depression was robustly associated with substance misuse in women 
only, which suggests that depression may be especially important for substance misuse risk in 
women. ADHD and conduct disorder symptoms co-occurring with depression and anxiety 
amplified the risk for substance misuse more in women than in men, possibly reflecting sex-
specific mechanisms in the development of alcohol or drug use problems. 
 
Clinical guidance 
 Screening for mood-related problems may help to identify children who are at risk of 
developing substance misuse in adolescence or early adulthood. 
 Mood-related psychopathology may be an important risk marker for substance misuse 
especially in women. 
 In both primary care and specialist services, it is important to assess for internalizing 
disorders even if the primary reason for referral is a neuropsychiatric disorder 
(ADHD), as comorbid internalizing and externalizing psychopathology may be 






Substance use disorders (SUDs) are associated with increased mortality as well as high 
economic costs and societal burden.1,2 Other psychiatric disorders often precede the onset of 
SUDs, but much remains unclear about the longitudinal associations between childhood 
psychopathology and SUDs. 3,4 Previous literature suggests at least two distinct risk factors 
for SUDs: externalizing  disorders characterized by behavioral disinhibition (i.e. ADHD, 
oppositional defiant disorder (ODD) and conduct disorder)3 and an internalizing disorders 
leading to SUDs possibly through self-medication behaviors used to alleviate feelings of 
anxiety and depression.4 There is consistent support for externalizing behaviors being 
associated with SUDs5,6, but findings on internalizing disorders remain inconclusive.7-9 A 
meta-analysis of longitudinal studies of children and adolescents found that depression, but 
not anxiety, was associated with the risk of subsequent SUDs.7 Findings on sex differences 
are also mixed: there is some cross-sectional and longitudinal evidence for internalizing 
psychopathology being a greater risk factor for SUDs in women than in men10,11, but some 
longitudinal studies report no sex differences.12 The inconclusive results may in part reflect 
variability in the measurement of internalizing disorders; many studies are based on 
community samples using self-report measures while only a few studies have used clinical 
diagnoses, and the association may depend on the severity of depression and anxiety.7 
It is also important to consider that SUDs and other psychiatric disorders have shared 
etiological factors such as genetic liability and environmental influences13,14, which could 
give rise to the observed associations. Standard epidemiological study designs cannot rule out 
the possibility that an observed association between internalizing psychopathology and SUDs 
is explained by such shared underlying liabilities. Twin and family studies, however, can 
account for shared familial factors and provide more robust evidence of a direct association 
between internalizing psychopathology in childhood or adolescence and subsequent SUDs.15 
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Only a few studies have examined the association between childhood/adolescent internalizing 
psychopathology and subsequent alcohol or drug use with genetically informative designs, 
but to our knowledge, none have investigated diagnosed SUDs specifically. Childhood 
depression was associated with adolescent alcohol use, but not drug use, in a sample of 
Finnish twins whereas social anxiety at the age of 12 was not associated with subsequent 
drug use.16,17 Another study conducted cross-sectional reciprocal causation twin modeling in 
the same data and concluded that there was inconclusive evidence for a causal path from 
childhood depression to adolescent alcohol use frequency.18 A Swedish longitudinal study of 
adolescent twins found that the association of anxiety and depressive symptoms with 
intoxication frequency was mostly explained by individual-specific environmental factors19, 
which is consistent with a possible causal relationship. In conclusion, there is some evidence 
that childhood/adolescent anxiety and depression are associated with alcohol use after 
familial factors are accounted for, but the findings are mixed and it remains unclear to what 
extent familial factors explain the association between internalizing psychopathology and 
SUDs. 
There is a high degree of co-occurrence between internalizing and externalizing 
problems20,21, but most prior research has focused on either internalizing or externalizing 
spectrum. Furthermore, the effect of their comorbidity on the risk of SUDs is not well 
understood. “Pure” externalizing psychopathology has been associated with a higher risk of 
subsequent alcohol and drug use in adolescents than comorbid externalizing and internalizing 
symptoms22, but other longitudinal studies have found the highest risk among individuals 
with both internalizing and externalizing psychopathology.23, 24 In two cross-sectional 
adolescent samples, comorbid depression and conduct disorder was associated with a higher 
risk of SUDs than would be expected considering only the effects of each disorder alone.25,26 
Further, a longitudinal study by Colder et al. suggested that in the absence of comorbid 
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externalizing behaviors, internalizing psychopathology was protective against substance 
use.22 These results highlight the importance of taking comorbid externalizing 
psychopathology into account when investigating the association between internalizing 
psychopathology and SUDs. 
To better understand the longitudinal association between internalizing problems and 
substance misuse, we investigated the association of childhood anxiety and mood-related 
problems with subsequent substance misuse in two prospective samples. First, in a large 
prospective twin sample linked with register data, we studied associations between parent-
reported internalizing psychopathology and register-based substance misuse, and examined 
whether they are accounted by familial factors. Second, we investigated associations in the 
general population between register-based anxiety and depressive disorders diagnosed in 
childhood and subsequent substance misuse, and controlled for familial factors shared by full 
siblings. In both samples, we also studied the role of externalizing comorbidity and sex in the 
development of substance misuse. 
Based on prior research, we expected to find a positive association between internalizing 
disorders and substance misuse. We further hypothesized the association to be at least 
partially explained by comorbid externalizing problems and familial factors. We did not have 






The Child and Adolescent Twin Study in Sweden (CATSS) 
The Child and Adolescent Twin Study in Sweden (CATSS) is a longitudinal study aiming to 
recruit all twins born in Sweden since July 1st 1992.27 From 2004 onwards, all 12-year-old 
(born 1992–1995) and 9-year-old (born July 1st 1995 and after) twins have been identified 
through the Swedish Twin Registry and their parents have been asked to participate in a 
telephone interview about their children’s somatic and mental health. The response rate for 
the present sample was 76%, with the mother being the informant in most families.27 The 
sample consists of 12,408 individuals born 1992–1998 whose parents participated in the age 
9/12 interview. There were 1846 monozygotic (MZ), 2192 same-sex dizygotic (DZ), and 
2043 opposite-sex DZ twin pairs. The data also included 103 pairs with unknown zygosity 
and 40 individuals without their co-twin in the study, who were included in the individual-
level analyses. Zygosity was determined with 48 single nucleotide polymorphisms, or in case 
DNA information was not available, by an algorithm based on a questionnaire on twin 
similarity.27 The CATSS study was approved by the Karolinska Institute Ethical Review 
Board, and parents provided consent for their children to participate. 
 
Population sample 
In the population sample, we included all individuals born in Sweden in 1984–2000 from the 
Total Population register (N=1,768,516). The CATSS twin cohort can be considered a sub-
sample within the population sample. The population sample was linked to the National 
Patient Register (NPR)28, the Cause of Death Register, the Migration Register, and the Multi-
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Generation Register.29 We used the Multi-Generation Register and the Swedish Twin 
Registry to identify full siblings and MZ and DZ twins, respectively. We excluded 
individuals whose parents could not be identified from the Multi-Generation Register 
(n=23,834), which is required for linking family members. The use of nationwide registers 
has been approved by the Regional Ethical Review Board in Stockholm. Informed consent 
requirement was waived because participants are not identifiable at any time. 
 
Measures 
CATSS: Internalizing and externalizing measures 
In the CATSS sample, anxiety and mood problems, ADHD, and conduct disorder were 
assessed with the Autism - Tics, AD/HD and other Comorbidities Inventory (A-TAC), a 
validated instrument covering all common psychiatric disorders in child and adolescent 
psychiatry.30 The A-TAC items are worded to assess DSM-IV symptoms and well known 
clinical phenomena. The parents were asked to rate their 9/12-year-old children on each 
symptom on a dimensional scale: 0 = item does not apply; 0.5 = applies to some extent; and 1 
= applies in full. If the parent endorsed, fully or partially, at least one item as applying to their 
child, the interviewer proceeded to ask whether the symptoms had led to (1) dysfunction at 
school, among peers, or at home, and (2) suffering on the part of the child. A problem load 
score was then calculated as the sum of the two items on dysfunction and suffering (range 0-
2), with a cut-off for problems to be considered significant at ≥ 1, indicating either that at 
least one of the problem questions was fully endorsed or that both were endorsed to some 
extent.31 
Anxiety-related problems were assessed with the A-TAC based on items related to panic 
attacks, fears, general anxiousness, and social withdrawal. The A-TAC mood scale included 
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items related to e.g. depressed mood, feelings of worthlessness, lack of self-confidence, 
psychosomatic symptoms, and self-harm (see Table S1 for a list of the items, available 
online). For both anxiety and mood problems, we used a binary variable derived from the 
corresponding problem load score in order to capture cases with more severe or debilitating 
forms of psychopathology (coded: 0 = no problematic symptoms, 1 = problematic 
symptoms). The A-TAC scales on symptoms of ADHD, ODD, and conduct disorder were 
used as covariates in the primary analyses (continuous variables). 
 
Population sample: Internalizing and externalizing measures 
The population sample was linked to the NPR using the unique personal identity number 
assigned to each individual living in Sweden.32 The NPR covers all inpatient (1973–) and 
outpatient (2001–) diagnoses with data available in the current study until December 31, 
2013. We included ICD-9 and ICD-10 diagnoses of anxiety and depression (diagnosis codes 
listed in Table S2, available online) registered before age 13. We also included diagnoses of 
anxiety disorders with onset specific to childhood (i.e., separation anxiety disorder and 
childhood social anxiety disorder) registered before age 13. We included diagnoses of ADHD 
and conduct disorders as covariates. We also conducted a sensitivity analysis with autism as a 
covariate to control for a potential selection bias: for instance, children who received an 
anxiety/depression diagnosis might have been in the clinic primarily for neuropsychiatric 
assessment. 
 
CATSS: Internalizing and externalizing comorbidity in childhood 
To illuminate the consequences of externalizing comorbidity, we also investigated the role of 
comorbid internalizing and externalizing psychopathology on the risk of substance misuse. 
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An individual was classified as having internalizing psychopathology if the A-TAC 
symptoms exceeded the “significant impairment” cut-off (≥ 1) in the anxiety or mood 
problems scale. Externalizing psychopathology was defined as fulfilling the DSM-IV 
diagnostic symptom criteria for ADHD, ODD, or conduct disorder in the A-TAC (i.e., the 
continuous symptom count variable was categorized for these analyses). Each individual was 
classified as belonging to one of the following groups: 1) no psychopathology, 2) 
internalizing psychopathology only, 3) externalizing psychopathology only, 4) both 
internalizing and externalizing psychopathology. 
 
Population sample: Internalizing and externalizing comorbidity in childhood 
Similarly, we investigated the effect of externalizing comorbidity in the population sample. 
Internalizing psychopathology was defined as an ICD-9/10 diagnosis of anxiety or depressive 
disorder, or childhood specific anxiety disorder. Externalizing psychopathology was defined 
as an ICD-9/10 diagnosis of ADHD or conduct disorders (for diagnosis codes, see Table S2, 
available online). Each individual was classified to one of the following groups: 1) no 
psychopathology, 2) internalizing psychopathology only, 3) externalizing psychopathology 
only, 4) both internalizing and externalizing psychopathology. 
 
CATSS and the population sample: Substance misuse 
We studied substance misuse based on information from the nationwide Swedish registries by 
linking individuals in the two samples to the NPR and the Crime register. Substance misuse 
was defined as having an ICD-9/10 diagnosis of alcohol or drug use disorder or an 
alcohol/drug-related criminal conviction in the registries. The Crime Register includes district 
court convictions among people aged 15 and older since 1973, and follow-up was available 
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until December 31, 2013. Thus, the maximum age at the end of follow-up was 21 years in 
CATSS and 29 years in the population sample. To ensure that the study design was 
prospective, we studied substance misuse starting at age 13 and excluded individuals with 
substance misuse registrations before age 13 (CATSS n=17, register based sample n=733). 
Analyses 
CATSS and the population sample: Associations of childhood psychopathology and 
substance misuse 
We used Cox proportional hazards regression, with age as the underlying time-scale, to 
estimate the effect of childhood anxiety and mood-related problems on the risk of subsequent 
substance misuse. The participants of both CATSS and the population-based sample were 
followed up through the nationwide registers from their 13th birthday until the date of first 
substance misuse event, emigration, death, or December 31, 2013, whichever occurred first. 
We accounted for the non-independence of observations in families by using a cluster-robust 
sandwich estimator for standard errors. Since men and women have a different prevalence of 
substance misuse, we allowed sex-specific baseline hazards and estimated all models 
stratified by sex. We also present separate coefficients for men and women. All models were 
adjusted for birth year, and the models including both men and women were also adjusted for 
sex. 
 
CATSS and the population sample: Within-family analyses 
Several factors may confound the association between childhood psychopathology and 
substance misuse. The association may be explained by 1) genetic factors, which are shared 
completely by MZ co-twins, and on average, 50% by DZ co-twins and full siblings, 2) 
environmental factors that are shared both by co-twins and siblings reared together, and 3) 
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non-shared environmental factors which make co-twins and siblings dissimilar. Stratified 
analyses within twin pairs and clusters of siblings can thus account for the contribution of 
unmeasured genetic and shared environmental factors.33 We conducted within-family 
analyses with stratified Cox regression models within twin pairs in the CATSS sample and 
within clusters of full siblings in the population sample. A stratified model within full 
siblings accounts for all unmeasured genetic and environmental factors shared by siblings, 
and thus adjusts for 50% of genetic factors and all shared environmental factors. In addition, 
we stratified the models by sex to account for different baseline hazards in men and women, 
and we also report results from separate models for men and women. 
 
CATSS and population sample: Internalizing and externalizing comorbidity in childhood 
In both samples, we estimated associations of comorbid and non-comorbid internalizing and 
externalizing with substance misuse in Cox regression models, using the “no 
psychopathology” group as the reference category. Internalizing psychopathology only, 
externalizing psychopathology only, and both internalizing and externalizing 
psychopathology groups were compared to the no psychopathology group in terms of their 





Table 1 shows the distribution of internalizing and externalizing psychopathology in 
childhood, and register-based substance misuse since age 13 in the CATSS and population 
samples. The median age of first registered substance use disorder diagnosis or substance 
use-related criminal conviction was 17.2 in the CATSS sample and 18.4 in the population 
sample. In the population sample, substance use disorders were on average diagnosed earlier 
among those with anxiety/depressive disorders than among those with ADHD (Table S3, 
available online). 
 
Associations of childhood anxiety and mood problems with subsequent substance misuse in 
CATSS 
Childhood mood problems were associated with subsequent substance misuse (hazard ratio, 
HR=2.28 [95% CI: 1.69–3.08]) whereas the estimated association for anxiety-related 
problems was statistically non-significant (Table 2). Confidence intervals for the associations 
in men and women (HR=1.96 [1.34–2.90] vs. 2.97 [1.82–4.84]) were overlapping. When 
childhood symptoms of ADHD and conduct problems were accounted for, the association 
between mood problems and substance misuse was completely attenuated in men but 
remained evident in women. 
 
Associations of childhood anxiety and depressive disorders with subsequent substance misuse 
in the population sample 
Anxiety and depressive disorders registered before age 13 were associated with an elevated 
risk of subsequent substance misuse (Table 3). Childhood-specific anxiety disorders were 
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also associated with substance misuse but the estimate was imprecise and non-significant. As 
seen in Table 3, the associations were stronger in women than in men for both depression 
(HR=3.65 [2.86–4.64] vs. HR=2.35 [1.93–2.87], p=.006) and anxiety disorders (HR=1.77 
[1.49–2.11] vs. HR=1.34 [1.12–1.59], p=.026), whereas no sex difference was found for 
childhood specific anxiety disorders (HR=1.55 [0.74-3.26] vs. HR=1.27 [0.72-2.23], p=.668). 
After adjusting for ADHD and conduct disorders, anxiety and depressive disorders were still 
associated with an elevated risk for substance misuse in women. In men, anxiety and 
depression were associated with a lower risk for substance misuse when adjusted for 
externalizing disorders. In within-family analyses, the HR for depression increased in men 
but attenuated in women. A similar trend was found for the association between anxiety 
disorders and substance misuse. As a sensitivity analysis, we further adjusted the models for 
autism (Table S4, available online), but there was little change in the estimates. 
 
Internalizing and externalizing comorbidity in CATSS and the population sample 
Having comorbid externalizing and internalizing problems seemed to be associated with an 
especially elevated risk for substance misuse in women in both samples. In contrast, no such 
pattern was present in men (Figure 1, Table S5; available online). However, especially in the 





 In two prospective family-based samples, we found consistent support for mood-related 
psychopathology being associated with an elevated risk of subsequent substance misuse, and 
for a different developmental pattern of substance misuse in men and women. Our study had 
notable strengths. First, we studied substance misuse as identified from nationwide registers, 
which rules out reporting biases common in studies of alcohol and drug use and problems. To 
capture a wider range of substance use problems, we included alcohol and drug related 
criminal convictions in addition to diagnoses of substance use disorders. Second, using two 
different samples, we assessed childhood anxiety and depressive disorders with parental 
reports of symptoms and with register-based diagnoses. The use of two complementary 
methods adds to the credibility of our findings. Third, both the twin cohort and register-based 
data enabled studying the role of comorbid externalizing problems, based on parental reports 
and registered diagnoses, respectively. Finally, both samples had data on siblings, allowing 
within-family analyses to investigate the contribution of familial liabilities. 
We found that childhood mood problems were associated with an elevated risk of subsequent 
substance misuse, consistent with findings from earlier community-based studies.7 The 
estimates for anxiety were imprecise, and the exact magnitude of elevated risk was thus 
unclear. In the population-based sample of nearly 2 million individuals in Sweden, both 
anxiety and depressive disorders in childhood were associated with an elevated risk of 
substance misuse. Childhood-specific anxiety diagnoses, i.e., separation anxiety and 
childhood social anxiety, were also associated with an increased risk of substance misuse. 
However, this association was reversed when accounting for comorbid externalizing 
disorders, in line with an earlier study.22 Associations between different internalizing 
problems and substance misuse were similar across samples, although the hazard ratios were 
slightly higher in the population sample. Similar findings have been reported in previous 
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studies where the associations between SUDs and anxiety and depressive disorders were 
more elevated in register-based samples compared to community-based survey studies34-36. 
More elevated risks in studies using national patient registries may reflect the effect of more 
severe psychopathology on the risk of substance misuse37, but also the common method bias: 
associations between diagnoses acquired from a single source such as the NPR might reflect 
treatment/diagnostic policies rather than actual relationships between disorders. We partially 
addressed this issue by including substance use-related criminal convictions from another 
source in our definition of substance misuse. 
Findings from both of our samples consistently suggest that the developmental pathway from 
childhood mood problems to substance misuse may be different for men and women. The 
developmental pathways framework includes the concept of equifinality, which denotes that a 
common outcome such as SUD can develop over time from different starting points.38 When 
externalizing symptoms were accounted for, mood problems predicted substance misuse only 
among women in the CATSS sample. Similarly, the elevated risk of substance misuse in 
those with anxiety and depressive disorders was explained by comorbid externalizing 
disorders in men but not in women in the population sample. In both samples, the 
associations were generally stronger in women. Taken together, our findings suggest that the 
internalizing pathway to substance misuse may be more prominent in women than in men. 
However, there was one exception: we found either no association or an inverse association 
between mood problems/depression and substance misuse in men after adjusting for 
externalizing disorders at the individual level, yet elevated risk was apparent in within-family 
analyses. The finding indicates that genetic or shared environmental factors may mask the 
association between depression and substance misuse in men when co-occurring 
externalizing disorders are accounted for. 
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The association between anxiety/mood problems and substance misuse appeared to be 
partially explained by familial factors in both samples, consistent with other studies 
indicating SUDs and internalizing disorders sharing etiological factors such as genetic 
liability and environmental influences.16-18,36,39,40 These findings highlight the need to take 
shared underlying liabilities into account when investigating the link between internalizing 
psychopathology and substance misuse, as the associations seems to at least partially reflect 
unmeasured genetic and shared environmental factors that affect both traits, and not 
necessarily a direct effect of internalizing disorders on substance misuse. There was 
attenuation in the estimates in within-family analyses as compared to the individual level, but 
as the estimates were often imprecise, strong conclusions cannot be drawn on the role of 
familial factors. Diagnostic misclassification may also introduce bias which appears as 
evidence for familial confounding in within-family analyses.41 Further, as we were unable to 
conduct separate analyses within MZ and DZ twins due to lack of statistical power, it remains 
unclear to what extent shared environmental and genetic factors contributed to the familial 
effects. 
Our results also suggested that the effect of comorbidity of internalizing and externalizing 
psychopathology on substance misuse may depend on sex. In men, externalizing 
psychopathology without co-occurring internalizing problems was associated with the highest 
risk of substance misuse. In contrast, comorbidity of internalizing and externalizing 
psychopathology in women seemed to associate with an especially high risk of substance 
misuse. These results may reflect sex-specific mechanisms in the development of substance 
misuse: in women, comorbid externalizing problems appear to amplify the risk of substance 
misuse in those with internalizing psychopathology. In men, externalizing behavior is central 
in the development of substance misuse, and internalizing disorders seem to attenuate rather 
than increase the risk of substance misuse. Our findings are in line with earlier studies 
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showing a higher risk of substance misuse in “pure” externalizing problems as compared to 
comorbidity22, as well as other studies reporting similar risks in comorbid and pure 
externalizing groups.23,24 However, it should be noted that some estimates for men and 
women had overlapping confidence intervals, and thus definite conclusions cannot be drawn. 
Our findings imply that in both primary care and specialist services, when a child is referred 
for an assessment for ADHD or other behavioral problems, additional assessment for 
comorbid internalizing psychopathology is warranted, because comorbid internalizing and 
externalizing psychopathology may be associated with an increased risk of alcohol or drug 
use problems, especially in women. On the other hand, ADHD is often underdiagnosed in 
girls due to the symptoms being less overt than in boys, and because internalizing 
psychopathology can overshadow symptoms of ADHD and complicate diagnostic 
assessment.42 Underdiagnosing of ADHD could also inflate the association between 
internalizing disorders and substance misuse, particularly in older birth cohorts where 
underdiagnosing was more common. Further, mood problems/depression was a risk marker 
for substance misuse independent of comorbid externalizing problems. Screening for mood-
related problems may thus help identifying children who are at risk of developing substance 
misuse in adolescence or early adulthood. Our findings also emphasize the need to consider 
how the anxiety phenotype is measured, as the association with substance misuse depended 
on the severity (clinical diagnosis vs. parental report of symptoms) and type of anxiety 
disorder. 
Several limitations should be noted. First, although the factor structure and neuropsychiatric 
sub-scales of A-TAC are well validated31,43, psychometric properties of the mood and anxiety 
problem scales have not been examined. The mood problems scale includes a variety of 
symptoms and problematic behaviors and may not capture primarily depression. Parents are 
also more accurate at identifying externalizing than internalizing symptoms in their children, 
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which may produce bias.44 Future studies are encouraged to replicate our study with other 
measures of mood and anxiety problems. For example, the current study did not include 
assessments of trauma-related psychopathology, which is associated with subsequent 
substance use problems.45 
Second, the present study did not include all cases of SUDs or internalizing and externalizing 
disorders, because the NPR only captures diagnosed cases among the treatment-seeking 
population in inpatient and outpatient clinics. Common psychiatric disorders are often treated 
at the primary care level in Sweden35, and some individuals do not seek treatment. This is 
also the reason why the population sample had a higher prevalence of neuropsychiatric 
disorders than internalizing and externalizing disorders. Individuals with a childhood 
diagnosis in the NPR are a selected group: children are likely to be referred to inpatient or 
outpatient psychiatric services either due to a need for neuropsychiatric assessment or 
because the problem is severe and cannot be treated in primary care. Further, depression and 
anxiety disorders are generally diagnosed later in life than autism where most cases are 
diagnosed before adolescence. We aimed to address the possible selection effects by not 
relying solely on the NPR data in the study but including the CATSS sample as well, and by 
conducting a sensitivity analysis where we adjusted for autism diagnoses. Our findings were 
generally similar regardless of the measurement of internalizing disorders, and adjustment for 
autism had little effect on the results, which increases the confidence that the associations are 
not due to selection bias. However, autism shares etiological factors with ADHD46, and did 
explain a small proportion of the association between internalizing disorders and substance 
misuse. Further, our results do not necessarily generalize beyond the population of 
individuals with SUDs with severe enough psychopathology to warrant specialist care, or 
who were convicted for substance-related offence. 
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Third, the maximum age at the end of follow-up was 21 or 29 years. Previous studies suggest 
earlier-onset SUDs to have distinct characteristics as compared to adult-onset SUDs47, which 
may also have affected the observed associations in the present study. Finally, the timing of 
substance misuse and internalizing disorders is another issue to consider, as the first 
registered diagnosis/conviction date does not correspond well with disorder onset. The 
analyses of the population sample in particular should be interpreted with this caveat, because 
it is likely that many individuals without a childhood diagnosis received a diagnosis later in 
life. 
In conclusion, we found evidence of an internalizing pathway to substance misuse in two 
large cohorts. Mood-related psychopathology in childhood was consistently associated with 
an elevated risk of substance misuse whereas the relationship of anxiety with substance 
misuse was complex and depended on the measurement and the type of anxiety disorder. 
Familial factors partially explained the observed associations. The developmental pattern of 
substance misuse was different for men and women: internalizing disorders were robustly 
associated with substance misuse in women only. Further, the role of comorbid externalizing 
psychopathology seemed to be sex-specific, as externalizing psychopathology amplified the 
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Table 1: Childhood Psychopathology and Substance Misuse in the CATSS Sample and the 
Population Sample 
  Total n (%) Men n (%) Women n (%) 
CATSS27    
Childhood psychopathology    
Mood problems 678 (5.5) 401 (6.3) 277 (4.6) 
Anxiety problems 187 (1.5) 101 (1.6) 86 (1.4) 
ADHDa 599 (4.8) 429 (6.7) 170 (2.8) 
Conduct disorder or ODDb 304 (2.5) 201 (3.2) 103 (1.7) 
Childhood comorbidity    
No childhood psychopathology 11,175 (90.1) 5,623 (88.0) 5,552 (92.2) 
Internalizing only 499 (4.0) 254 (4.0) 245 (4.1) 
Externalizing only 465 (3.8) 318 (5.0) 147 (2.4) 
Both internalizing and externalizing 269 (2.2) 192 (3.0) 77 (1.3) 
Substance misuse 411 (3.3) 254 (4.0) 157 (2.6) 
Population sample28    
Childhood psychopathology    
    Depression 1,873 (0.11) 1,103 (0.12) 770 (0.09) 
    Childhood-specific anxiety disorders 412 (0.02) 231 (0.03) 181 (0.02) 
    Anxiety disorders 5,300 (0.3) 2,573 (0.3) 2,727 (0.3) 
    ADHD  60,208 (3.4) 38,915 (4.3) 21,293 (2.5) 
    Conduct disorders 6,928 (0.4) 4,383 (0.5) 2,545 (0.3) 
    Autism 19,028 (1.1) 12,552 (1.4) 6,476 (0.8) 
Childhood comorbidity    
    No childhood psychopathology 1,699,841 (96.1) 865,288 (95.3) 834,553 (97.0) 
    Internalizing only 5,364 (0.3) 2,516 (0.3) 2,848 (0.3) 
    Externalizing only 61,476 (3.5) 39,468 (4.3) 22,008 (2.6) 
    Both internalizing and externalizing  1,835 (0.1) 1,178 (0.1) 657 (0.1) 
Substance misuse 102,150 (5.8) 66,137 (7.3) 36,013 (4.2) 
Note: CATSS27: Total n = 12,408; Men n = 6,387; Women n = 6,021; Population sample28: Total N = 
1,768,516, Men n = 908,450, Women n = 860,066. Externalizing = exceeding the DSM-IV cut-off of 
ADHD, ODD, or conduct disorder in the A-TAC in the CATSS sample, and having an ICD diagnosis of 
ADHD or conduct disorders in the population sample; Internalizing = exceeding the “significant 
impairment” cut-off of anxiety or mood problems scales in the A-TAC in the CATSS sample, and 
having an ICD diagnosis of anxiety or depressive disorders in the population sample 
 
a Frequencies of individuals exceeding the DSM-IV cut-off in the A-TAC (ADHD symptom scale mean 
= 1.8 [SD = 2.8]) 
b Frequencies of individuals exceeding the DSM-IV cut-off in the A-TAC (ODD symptom scale mean 





Table 2: Hazard Ratios (95% CIs)  for the Association of Childhood Anxiety and Mood Problems 
With Substance Misuse in the CATSS sample 
  
Anxiety 
problems   Mood problems 
Total   
Individual level   
  Minimally adjusted 1.12 (0.51–2.25)  2.28 (1.69–3.08) 
  Adjusted for externalizing 0.48 (0.22–1.06)  1.26 (0.87–1.85) 
Within-family   
  Minimally adjusted 0.80 (0.21-2.98) 2.67 (1.24-5.74) 
  Adjusted for externalizing 0.44 (0.11–1.82) 2.16 (0.93–5.00) 
Men    
Individual level    
  Minimally adjusted 1.58 (0.75-3.32) 1.96 (1.34–2.90) 
  Adjusted for externalizing 0.60 (0.25-1.42) 0.99 (0.61–1.60) 
Within-family   
  Minimally adjusted 1.00 (0.20-4.95)  3.25 (1.06-9.97) 
  Adjusted for externalizing 0.52 (0.09-2.87)  2.47 (0.75–8.20) 
Women    
Individual level    
   Minimally adjusted 0.37 (0.05-2.67)  2.97 (1.82–4.84) 
   Adjusted for externalizing 0.22 (0.03-1.57)  1.86 (1.11–3.11) 
Within-family    
   Minimally adjusted 0.50 (0.03-8.95)  2.20 (0.76-6.33) 
   Adjusted for externalizing 0.32 (0.03-3.68)  1.91 (0.64–5.78) 
Note: Bolded coefficients indicate the 95% CI does not include 1. Externalizing = Symptoms of 
ADHD, ODD, and conduct disorder; Minimally adjusted = Adjusted for sex and birth year 
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Table 3: Hazard Ratios for the Association of Childhood Anxiety and Depressive Disorders With 
Substance Misuse (95% CIs) in the Population Sample 
  
  Childhood-specific  
  anxiety disorders Anxiety disorders Depression 
Total    
Individual level    
  Minimally adjusted 1.36 (0.87–2.13) 1.52 (1.35–1.73) 2.75 (2.36–3.20) 
  Adjusted for externalizing  0.56 (0.36–0.89) 0.99 (0.88–1.12) 0.98 (0.85–1.15) 
Within-family    
  Minimally adjusted 3.34 (0.68–16.47) 1.21 (0.86–1.68) 2.17 (1.37–3.45) 
  Adjusted for externalizing  2.75 (0.54–13.97) 0.91 (0.64–1.29) 1.52 (0.93–2.51) 
Men    
Individual level    
   Minimally adjusted 1.27 (0.72-2.23) 1.34 (1.12–1.59) 2.35 (1.93–2.87) 
   Adjusted for externalizing  0.51 (0.29-0.90) 0.80 (0.67–0.96) 0.77 (0.63–0.94) 
Within-family    
   Minimally adjusted NA 1.44 (0.89–2.31) 3.21 (1.71–6.06) 
   Adjusted for externalizing  NA 1.01 (0.61–1.65) 2.35 (1.19–4.62) 
Women    
Individual level    
   Minimally adjusted 1.55 (0.74-3.26) 1.77 (1.49–2.11) 3.65 (2.86–4.64) 
   Adjusted for externalizing  0.69 (0.33-1.45) 1.29 (1.08–1.54) 1.67 (1.33–2.16) 
Within-family    
   Minimally adjusted NA 1.01 (0.63–1.62) 1.24 (0.61–2.51) 
   Adjusted for externalizing  NA 0.81 (0.50–1.34) 0.91 (0.42–1.94) 
Note: Bolded coefficients indicate the 95% CI does not include 1. Externalizing = ICD diagnoses of 
ADHD and conduct disorders; Minimally adjusted = Adjusted for sex and birth year; NA = Model 
could not be estimated 
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Figure Titles and Captions 
 
 
Figure 1: Hazard Ratios (with 95% CIs) for the Association of Childhood Comorbid and 
Non-Comorbid Psychopathology With Substance Misuse in the CATSS (left) and Population 
Sample (right) 
